研修報告
糖尿病患者における腎臓病の発症予防を目的とした生活習慣介入の費用対効果分析
2023 年 72 巻 2 号 p. 177-178
詳細
2023 年 72 巻 2 号 p. 177-178
Objectives: The cost-effectiveness of lifestyle intervention for preventing kidney disease in patients with type 2 diabetes was not fully elucidated.
Methods: We developed the Markov model with a Japanese healthcare payer’s perspective to examine the cost-effectiveness of lifestyle interventions for preventing the development of kidney disease among patients with diabetes. Model parameters, including the lifestyle intervention effect, were derived from the results of the published literatures. The incremental cost-effectiveness ratios (ICER) were calculated from the difference in cost and quality-adjusted life years (QALY) between the lifestyle intervention and diabetes support education group.
Results: The ICER for the lifestyle intervention compared with the diabetes support education was JPY 1,510,838 per QALY.
Conclusions: The results of the present study showed that the lifestyle intervention for the prevention of kidney disease in patients with diabetes would be cost-effective from a Japanese healthcare payer’s perspective compared to the diabetes support education.
